Published in Sci Rep on June 13, 2016
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov (2007) 11.46
Prostate cancer epidemiology. Lancet (2003) 6.30
Cancer statistics, 1994. CA Cancer J Clin (1994) 4.14
Metastatic prostate cancer in a transgenic mouse. Cancer Res (1996) 4.02
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate (2003) 3.44
Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer (2010) 2.51
Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis (1999) 2.37
Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest (2002) 2.26
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PLoS One (2013) 2.10
Angiopoietins in angiogenesis. Cancer Lett (2012) 1.69
The prostate: an increasing medical problem. Prostate (1990) 1.67
Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and, therefore, lowers the risk of metastases. Am J Clin Pathol (2004) 1.63
BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. J Cell Sci (2010) 1.43
Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res (1993) 1.29
Metformin in cancer treatment and prevention. Annu Rev Med (2014) 1.23
Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am J Pathol (2004) 1.21
Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res (1998) 1.18
Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer. Prostate (2005) 1.18
Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade. Int J Oncol (2009) 1.15
Metformin and cancer. Eur J Pharmacol (2013) 1.11
Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. J Clin Invest (2004) 1.10
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 1.04
A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model. Toxicol Pathol (2003) 1.04
Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol (2002) 1.03
Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A. Sci Signal (2013) 1.01
Chemopreventive and bioenergetic signaling effects of PDK1/Akt pathway inhibition in a transgenic mouse model of prostate cancer. Toxicol Pathol (2007) 0.97
Models of metastatic prostate cancer: a transgenic perspective. Prostate Cancer Prostatic Dis (2003) 0.94
Expression and prognostic significance of angiopoietin in colorectal carcinoma. J Surg Oncol (2006) 0.94
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry. Diabetes Res Clin Pract (2010) 0.93
Type 2 diabetes and oral antihyperglycemic drugs. Curr Med Chem (2008) 0.91
ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells. PLoS One (2014) 0.89
Dietary methionine restriction inhibits prostatic intraepithelial neoplasia in TRAMP mice. Prostate (2014) 0.87
Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis. Oncotarget (2014) 0.85
Virtual in vivo biopsy map of early prostate neoplasm in TRAMP mice by MRI. Prostate (2009) 0.82
Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer. BJU Int (2005) 0.81
Enhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoprotein. PLoS One (2011) 0.81
Significant correlation between the breakpoints of rare clonal aberrations in benign solid tumors and the assignment of HMGIY retropseudogenes. Cancer Genet Cytogenet (2001) 0.81
Cytogenetic aberrations and the development of uterine leiomyomata. J Obstet Gynaecol Res (2010) 0.81
Disruption of arginase II alters prostate tumor formation in TRAMP mice. Prostate (2008) 0.81
The high-mobility group I-Y transcription factor is involved in cerebral ischemia and modulates the expression of angiogenic proteins. Neuroscience (2014) 0.81
Improving the therapeutic potential of endostatin by fusing it with the BAX BH3 death domain. Cell Death Dis (2014) 0.77
Molecular profiling in prostate cancer. Cancer Metastasis Rev (2001) 0.77
P-selectin-mediated LOX expression promotes insulinoma growth in Rip1-Tag2 mice by increasing tissue stiffness. Int J Biol Sci (2016) 0.75
Andrographolide Inhibits Angiogenesis by Inhibiting the Mir-21-5p/TIMP3 Signaling Pathway. Int J Biol Sci (2017) 0.75
Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer. Int J Biol Sci (2017) 0.75